Showing results (21-30 of 115) with videos related to

Sort By:
Pageof 12
Journal of Applied Research in Intellectual Disabilities : JARID|March 7, 2026
Key Factors for Quality End-of-Life Care for People With Intellectual Disabilities. A Critical Interpretive Synthesis Review Using a 'Best-Fit' Framework ApproachMargaret Haigh, Philip McCallion, Mary McCarron, et al.
Molecular and Cellular Biology|December 17, 2004
Ras-Raf-Arf signaling critically depends on the Dmp1 transcription factorRamesh Sreeramaneni, Asif Chaudhry, Martin McMahon, et al.
Genes & Development|March 5, 2014
Diminished WNT -> β-catenin -> c-MYC signaling is a barrier for malignant progression of BRAFV600E-induced lung tumorsJoseph Juan, Teruyuki Muraguchi, Gioia Iezza, et al.
Cancer Research|April 23, 2011
Mutationally activated BRAF(V600E) elicits papillary thyroid cancer in the adult mouseRoch-Philippe Charles, Gioia Iezza, Elena Amendola, et al.
Novartis Foundation Symposium|February 28, 2008
A model of intussusceptive angiogenesisMax Levin, Andrew J Ewald, Martin McMahon, et al.
Cancer Research|May 3, 2003
Inhibition of the Raf/MEK/ERK pathway up-regulates expression of the coxsackievirus and adenovirus receptor in cancer cellsMario Anders, Christine Christian, Martin McMahon, et al.
Pigment Cell & Melanoma Research|February 25, 2017
PIK3CA-mutated melanoma cells rely on cooperative signaling through mTORC1/2 for sustained proliferationJillian M Silva, Marian M Deuker, Bruce C Baguley, et al.
Cancer Discovery|December 5, 2014
PI3'-kinase inhibition forestalls the onset of MEK1/2 inhibitor resistance in BRAF-mutated melanomaMarian M Deuker, Victoria Marsh Durban, Wayne A Phillips, et al.
Genes & Development|February 15, 2007
A new mouse model to explore the initiation, progression, and therapy of BRAFV600E-induced lung tumorsDavid Dankort, Elena Filenova, Manuel Collado, et al.
Pageof 12